These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11989542)

  • 21. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors.
    Cheng HF; Harris RC
    Curr Pharm Des; 2005; 11(14):1795-804. PubMed ID: 15892676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of congestive heart failure in the elderly: emphasis on renal functional changes and impact of therapy.
    Chau WL; Burnett JC
    Coron Artery Dis; 1997; 8(8-9):505-9. PubMed ID: 9431478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2.
    Gupta A; Rhodes GJ; Berg DT; Gerlitz B; Molitoris BA; Grinnell BW
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F245-54. PubMed ID: 17409278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non-steroidal anti-inflammatory agent and angiotensin converting enzyme inhibitor: a dangerous combination during postoperative period].
    Badid C; Chambrier C; Aouifi A; Boucaud C; Boulétreau P
    Ann Fr Anesth Reanim; 1997; 16(1):55-7. PubMed ID: 9686097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-Induced Kidney Injury in the Elderly.
    Khan S; Loi V; Rosner MH
    Drugs Aging; 2017 Oct; 34(10):729-741. PubMed ID: 28815461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. More on the "Triple Whammy": antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury - a case/non-case study in the French pharmacovigilance database.
    Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
    Ren Fail; 2014 Aug; 36(7):1166-8. PubMed ID: 24826803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the renin-angiotensin-aldosterone axis in later life.
    Belmin J; Lévy BI; Michel JB
    Drugs Aging; 1994 Nov; 5(5):391-400. PubMed ID: 7833591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
    Wolf G; Ritz E
    Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential role of platelet activating factor in acute renal failure.
    López-Novoa JM
    Kidney Int; 1999 May; 55(5):1672-82. PubMed ID: 10231429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of AGEs in diabetic nephropathy.
    Fukami K; Yamagishi S; Ueda S; Okuda S
    Curr Pharm Des; 2008; 14(10):946-52. PubMed ID: 18473844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin-angiotensin system, converting-enzyme inhibition and kidney function in aging female rats.
    Corman B; Michel JB
    Am J Physiol; 1986 Sep; 251(3 Pt 2):R450-5. PubMed ID: 3019163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelins in the normal and diseased kidney.
    Kohan DE
    Am J Kidney Dis; 1997 Jan; 29(1):2-26. PubMed ID: 9002526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal prostaglandin synthesis and angiotensin-converting enzyme inhibition.
    Wilson TW
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S39-44. PubMed ID: 1382164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of endothelins in hypertension.
    Feldstein C; Romero C
    Am J Ther; 2007; 14(2):147-53. PubMed ID: 17414582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of platelet-activating factor in the modulation of vascular tone in the isolated perfused rabbit kidney.
    Cailleaux S; Lopes-Martins RA; Aimbire F; Cordeiro RS; Tibiriçá E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):505-11. PubMed ID: 10431763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
    De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
    Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrarenal renin-angiotensin system in renal physiology and pathophysiology.
    Johnston CI; Fabris B; Jandeleit K
    Kidney Int Suppl; 1993 Jul; 42():S59-63. PubMed ID: 8361131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute kidney injury post-major orthopaedic surgery: A single-Centre case-control study.
    Ying T; Chan S; Lane S; Somerville C
    Nephrology (Carlton); 2018 Feb; 23(2):126-132. PubMed ID: 27706879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS.
    Brosnihan KB; Li P; Ganten D; Ferrario CM
    Am J Physiol; 1997 Dec; 273(6):R1908-15. PubMed ID: 9435644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.